Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

SS Innovations International, Inc. (SSII) Cash Flow Statement

SS Innovations International, Inc. (SSII) generated -$15.5M of operating cash flow over the twelve months to 2026-06-30, spent $2.7M on capital expenditure and had free cash flow of -$18.2M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SSIISS Innovations International, Inc.Follow SSII — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
450.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days
LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-15.4-9.5-18.5-15.5
Capital expenditure0.50.73.7-2.7
Free cash flow-15.8-10.2-22.2-18.2
Stock-based compensation9.714.38.1—

USD millions · SEC XBRL

SS Innovations International, Inc. — questions

What is SS Innovations International, Inc.'s operating cash flow?
-$15.5M over the twelve months to 2026-06-30.
How much does SS Innovations International, Inc. spend on capital expenditure?
$2.7M over the twelve months to 2026-06-30.
What is SS Innovations International, Inc.'s free cash flow?
-$18.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from SS Innovations International, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.